Official UK procurement notice
NHS National Framework for Aripiprazole prolonged release injection
Authority: NHS England (Central government)
Re-procurement plannedNHS National Framework for Vedolizumab Injection · tender expected
What is being bought
Published requirement descriptionProject title: NHS National Framework for Aripiprazole prolonged release injection commencing 1st February 2027
Offer reference number: CM/TNS/26/5741
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5741 Aripiprazole prolonged release injection
Lot 1 CESW 01/02/2027 to 30/09/2027 (8 months)
Lot 2 NWLN 01/02/2027 to 31/01/2029 (24 months)
Lot 3 LSNE 01/02/2027 to 31/05/2028 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 4 bids received · 3 suppliers appointed
- Framework period
- 2 yrs · up to 4 yrs from 1 Feb 2027
Who may buy through it
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Published description of the framework
Please refer to the ITO Documents for the Operation Description
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£24,467,000
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (1)
- Price is not the only award criterion: 100%
Published award criteria (1)
- Price is not the only award criterion
- Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
- “NHS National Framework for Aripiprazole prolonged release injection” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 12 Mar 2026, 15:56 GMT
- Last source update
- 25 Aug 2026, 17:56 BST
- Award evaluation window
- Submission end – 29 Jul 2026
- Authority reference
C434008- FTS notice number
2026/S 000-049710- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0668bfFind a Tender
How it was run
Official notice- Appointment period ends
- 26 Jun 2026, 13:00 BST
- Clarification deadline
- 19 Jun 2026, 12:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional info obtained from the abovementioned address
Tenders must be submitted to the abovementioned address
Timeline
12 Mar 2026 → 1 Feb 2027 · 10 dates- Planning notice published224 days ago12 Mar 2026, 15:56 GMT
- Market engagement174 days ago30 Apr 2026, 23:59 BST
NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.
The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.
Please contact [email protected] or [email protected] to register your interest in tendering for this framework.
- Tender notice published148 days ago27 May 2026, 13:46 BST
- Next notice expected147 days ago27 May 2026, 23:59 BST
- Clarification questions by125 days ago19 Jun 2026, 12:00 BST
- Admission / appointment period ends118 days ago · period end, not a bid countdown26 Jun 2026, 13:00 BST
- Assessment summaries sent85 days ago29 Jul 2026, 00:00 BST
- Award decision expected by84 days ago29 Jul 2026, 23:59 BST
- Latest notice published58 days ago25 Aug 2026, 17:56 BST
- Today22 Oct 2026
- Contract startsin 102 days1 Feb 2027
Notice history
11 events · 5 releases on Find a Tender · since 12 Mar 2026- Pipeline notice published12 Mar 2026, 15:56 GMTUK1
- Preliminary market engagement notice published2 Apr 2026, 11:05 BSTUK2
- Published value updated to £30,000,0002 Apr 2026, 11:05 BSTwas £54,000,000
- Tender notice published27 May 2026, 13:46 BSTUK4
- Published value updated to £24,467,00027 May 2026, 13:46 BSTwas £30,000,000
- Status changed to active27 May 2026, 13:46 BST
- Deadline published: 26 Jun 2026, 13:00 BST27 May 2026, 13:46 BST
- Contract award notice published29 Jul 2026, 12:22 BSTUK6
- Status changed to complete29 Jul 2026, 12:22 BST
- Contract signature expected21 Aug 2026, 23:59 BSTscheduled
- Contract details notice published25 Aug 2026, 17:56 BSTUK7
Routine re-releases (5)
- 2026-04: 1 release · 2 Apr 2026
- 2026-03: 1 release · 12 Mar 2026
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Otsuka Pharmaceuticals (UK) LtdSME, Perennial Pharma Ltd, Sun Pharma UK Ltd1 Feb 2027 – 31 Jan 2029 · up to 31 Jan 2031Extensions: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. | £32,140,000 | 29 Jul 2026 | Awarded |
Contracts
NHS National Framework for Aripiprazole prolonged release injection · Otsuka Pharmaceuticals (UK) LtdSME, Perennial Pharma Ltd, Sun Pharma UK Ltd
- Signed
- 14 Aug 2026
- Value
- £32,140,000
- Period
- 1 Feb 2027 – 31 Jan 2029 · up to 31 Jan 2031 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 4final-stage tenders | 4 | 0 | — |
Who bid
- wonOtsuka Pharmaceuticals UK LimitedSME · South East England
- wonPerennial Pharma Ltd · East of England
- wonSun Pharma UK Ltd · Greater London
- did not winOrifarm UK · East of England
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
4 commercial parties on the notice · 3 awarded- Orifarm UKBidder / tenderer
- Otsuka Pharmaceuticals UK LimitedFramework contractor
- Perennial Pharma LtdFramework contractor
- Sun Pharma UK LtdFramework contractor
Official documents & specifications (18)
Official links; attachments are not copiedTender pack and attachments
- Bidding documents and specifications Document No. 05 - Selectt offer schedule instructions - CM-TNS-26-5741
- Bidding documents and specifications Document No. 05a Selectt offer schedule - CM-TNS-26-5741
- Bidding documents and specifications Document No. 05b Tender Product Listing and Usage
- Bidding documents and specifications Document No. 06 - Form of offer - CM-TNS-26-5741
- Bidding documents and specifications Document No. 08 - Confidential information schedule - CM-TNS-26-5741
- Bidding documents and specifications Document No. 09 - Pharmacy Purchasing Points List - CM-TNS-26-5741
- Bidding documents and specifications Document No. 10 - C434008 - Requirement Section 1. Procurement Specific Questionnaire (PSQ) CM-TNS-26-5741
- Signed contract UK7 CONTRACT COPY CM-TNS-26-5741 Aripiprazole
Show 5 more documents
- Bidding documents and specifications Document No. 07 - Quality control technical sheet - CM-TNS-26-5741
- Bidding documents and specifications Document No. 01 - Invitation to offer covering letter - CM-TNS-26-5741
- Bidding documents and specifications Document No. 02 - Terms of offer - CM-TNS-26-5741
- Bidding documents and specifications Document No. 03 - Framework Agreement and Terms and Conditions - CM-TNS-26-5741
- Bidding documents and specifications Document No. 04 - Quality Assurance Process - CM-TNS-26-5741
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender